ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002201
- Locations
- 🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States
A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002275
- Locations
- 🇺🇸
East Orange Veterans Administration Med Ctr, East Orange, New Jersey, United States
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00004580
- Locations
- 🇺🇸
Univ of Cincinnati Med Ctr / Holmes Div Mail Loc 0405, Cincinnati, Ohio, United States
🇺🇸Pacific Oaks Research, Beverly Hills, California, United States
🇺🇸Duke Univ Med Ctr / Infectious Disease Clinic, Durham, North Carolina, United States
A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 300
- Registration Number
- NCT00004581
- Locations
- 🇨🇦
Clinique Medicale L'Actuele, Montreal, Quebec, Canada
🇨🇦Montreal Chest Institute, Montreal, Quebec, Canada
🇺🇸Tower ID Med Associates, Los Angeles, California, United States
A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 660
- Registration Number
- NCT00004583
- Locations
- 🇺🇸
Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States
🇺🇸Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸Tower ID Med Associates, Los Angeles, California, United States
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 12
- Registration Number
- NCT00002036
- Locations
- 🇺🇸
Univ of Minnesota, Minneapolis, Minnesota, United States
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002223
- Locations
- 🇺🇸
Tower Infectious Diseases, Los Angeles, California, United States
🇺🇸Urgent Care Ctr / North Broward Hosp District, Fort Lauderdale, Florida, United States
🇺🇸Stephen Hauptman, Philadelphia, Pennsylvania, United States
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2015-01-16
- Lead Sponsor
- Abbott
- Registration Number
- NCT00002336
- Locations
- 🇺🇸
Dr Nelson Zide, Hollywood, Florida, United States
🇺🇸Houston Veterans Administration Med Ctr, Houston, Texas, United States
🇺🇸Univ of Arizona / Health Science Ctr, Tucson, Arizona, United States
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
- Conditions
- Interventions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Abbott
- Target Recruit Count
- 100
- Registration Number
- NCT00004578
- Locations
- 🇺🇸
Northwestern University Medical School, Chicago, Illinois, United States
🇺🇸University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-08-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 24
- Registration Number
- NCT00000971
- Locations
- 🇺🇸
Children's Hosp of Los Angeles, Los Angeles, California, United States
🇺🇸Natl Cancer Institute / HIV / AIDS Malignancy Branch, Bethesda, Maryland, United States